National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$57.00
add to cart

Rights & Permissions

topleft topright

Priorities for the National Vaccine Plan (2010)
Board on Population Health and Public Health Practice (BPH)

Citation Manager

. "Appendix B: Letter to the Committee from the National Vaccine Advisory Committee." Priorities for the National Vaccine Plan. Washington, DC: The National Academies Press, 2010.

Please select a format:

BibTeX EndNote RefMan


Page
241
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Priorities for the National Vaccine Plan

The NVAC feels that the draft National Vaccine Plan does not go far enough to address coordination of vaccine-related activities both at the Federal level and with non-governmental partners. This role was highlighted in the 1994 National Vaccine Plan, and again in the June 2008 Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office, which stated:

[T]he principal coordinating organization for the [National Vaccine Program] NVP is the National Vaccine Program Office (NVPO), within the Public Health Service (PHS). The NVPO’s responsibilities include providing overall leadership for the collaborative effort and monitoring the progress being made in achieving the plan’s goals. Within the PHS, the NVPO has the task of reviewing all budget requests associated with vaccine development and immunization programs to ensure that all major priorities are adequately covered and that there is no duplication of effort.

The NVAC urges the Institute of Medicine recommend as part of its critique of the draft National Vaccine Plan that the final Plan adequately and appropriately addresses the ability of the National Vaccine Program to coordinate between the many varied partners and stakeholders involved in immunization in the United States, and that it be given an adequate administrative structure and resources to do so.


Please don’t hesitate to contact me if I can provide more information on behalf of the Committee. I can be reached through the National Vaccine Program Office, HHS at 202-690-5566.

Sincerely,

Guthrie S. Birkhead, M.D., M.P.H.,

Chair

National Vaccine Advisory Committee

Page
241